Bajaj Finance, Coal India, Wipro, other stocks to track on Friday
Domestic equity benchmarks ended yet another volatile session mildly higher on Thursday led by buying in auto shares though selling pressure in financial stocks played spoilsport and limited the upside. Both headline indices closed 0.2 per cent higher, with the Sensex adding 128.3 points for the day to settle at 74,611.1 and the Nifty50 gaining 43.4 points to 22,648.2. Here's a list of a bunch of stocks that investors will keenly track in the last trading session of the week.
At 8:17 am, Gift Nifty futures traded higher by 0.46 per cent or 105.55 points at 22,879.5, indicating a positive opening for the Indian stock markets today. Domestic equity benchmarks ended yet another volatile session mildly higher on Thursday led by buying in auto shares though selling pressure in financial stocks played spoilsport and limited the upside. Both headline indices closed 0.2 per cent higher, with the Sensex adding 128.3 points for the day to settle at 74,611.1 and the Nifty50 gaining 43.4 points to 22,648.2. Here's a list of a bunch of stocks that investors will keenly track in the last trading session of the week:
Bajaj Finance
The RBI has lifted certain restrictions imposed on Bajaj Finance in November that stopped the NBFC from sanctioning and disbursing loans under its lending products eCOM and Insta EMI Card. The company can now sanction and disburse loans under the two segments, according to a regulatory filing on Thursday.
The regulator had imposed the restrictions citing non-adherence to the extant provisions of digital lending guidelines.
Wipro
Wipro said it had been selected by US-based Independent Health to implement its Medicare Prescription Payment Plan (MPPP360) platform for the upcoming open enrollment period.
Starting in 2025, the Medicare Prescription Payment Plan will allow enrollees to make capped monthly payments for out-of-pocket prescription drugs, among other changes, the IT firm said on Thursday.
Its MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions, simplifying prescription cost management for medicare recipients in Western New York.
Ajanta Pharma Q4 PAT jumps 66% driven by robust sales
After market hours on Thursday, Ajanta Pharma reported a 66 per cent year-on-year jump in consolidated net profit to Rs 203 crore for the March quarter. Its quarterly revenue grew to Rs 1,054 crore from Rs 882 crore a year ago, according to a regulatory filing.
Britannia, Titan, MRF, Godrej Properties March-quarter results due on Friday
Around 50 companies are all set to report their quarterly financial results on May 3, including Titan, Britannia, MRF, Godrej Properties, Tata Technologies, Tatva Chintan, Aarti Drugs, Inox Wind, MRPL and Raymond.
Coal India
Coal India has staged a strong quarterly performance.
After market hours on Thursday, the state-run coal behemoth reported a year-on-year jump of more than 26 per cent in consolidated net profit to Rs 8,682.2 crore for the January-March period, boosted by higher supplies of the dry fuel.
Federal Bank, Coforge, RailTel, Blue Dart
Besides Coal India, a string of companies including Federal Bank, Coforge, RailTel and Blue Dart reported their quarterly numbers on Thursday.
Coforge / Cigniti Technologies
The IT company posted weak Q4 results with profit declining 9.7 per cent on year, while revenues inched marginally higher by 1.5 per cent. Alongside, the company will buy up to 54 per cent stake in Coforge through an open offer at a price of Rs 1415 per share.
CEAT
The company posted mixed Q4 results with revenue recording a minor 4.1 per cent increase on year, while profit declined 19.4 per cent.
IEX
The company in its business update for April month informed that total volume during the month increased 14.1 per cent to 9044 MU. Also, day ahead market price has declined 6 per cent to 5.1 per unit, while day ahead market volume has also registered a decline of 5.25 per cent to 4,116 MU.
The company in its board meeting scheduled on May 7 will deliberate over the interim dividend for the FY 2024-25. The record date to be eligible for the dividend payout has been fixed at May 15, 2024.
Hindalco
CLSA has continued with its 'buy' rating on the stock with a raised target of Rs 770.